Patrick Scherrer
Fondateur chez The European Tech Tour Association
Profil
Patrick Scherrer is the founder of G-ray Switzerland SA (founded in 2014) and The European Tech Tour Association (founded in 1998).
He is currently the Director-Executive Board at Evolva SA since 2009.
Mr. Scherrer's former positions include Chief Executive Officer at Widmann Associates Ltd.
(2004-2013), Director-Strategy & New Business Development at Alascom, Inc. (1995-1998), Chairman at G-Ray Medical Sàrl, Director at Sensimed SA, Director at Coretech 5 SA, and Principal at Hewlett-Packard EMEA (1992).
Mr. Scherrer received an undergraduate degree from Université de Neuchâtel.
Postes actifs de Patrick Scherrer
| Sociétés | Poste | Début |
|---|---|---|
Evolva SA
 Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Corporate Officer/Principal | 18/11/2009 |
| The European Tech Tour Association | Fondateur | 10/03/2011 |
Anciens postes connus de Patrick Scherrer
| Sociétés | Poste | Fin |
|---|---|---|
| Widmann Associates Ltd. | Directeur Général | 01/01/2013 |
Alascom, Inc.
 Alascom, Inc. Specialty TelecommunicationsCommunications Alascom, Inc. provides communications services. It offers mobility, network Security and service, cloud, television, hosting and voice services. The company was founded 1969 and is headquartered in Anchorage, AK. | Corporate Officer/Principal | 01/01/1998 |
| Hewlett-Packard EMEA | Corporate Officer/Principal | 01/01/1992 |
G-ray Switzerland SA
 G-ray Switzerland SA Medical/Nursing ServicesHealth Services G-ray Switzerland SA is a private company based in Hauterive, Switzerland that was founded in 2014 by Patrick Scherrer, Hans von Känel, Daniel A. Rüfenacht, and Adolfo Fucci. The Swiss company specializes in radiographic imaging and new semiconductor assembly techniques, and has filed a number of revolutionary patents in these fields. The company has developed core skills in monolithic detectors with integrated high-resolution CMOS circuits, which have applications in various sectors such as automotive, aerospace, and medicine. Luis Pallares has been the CEO of the company since 2020. | Fondateur | - |
G-Ray Medical Sàrl
 G-Ray Medical Sàrl Medical SpecialtiesHealth Technology G-Ray Medical Sàrl is a private company based in Hauterive, Switzerland. The Swiss company manufactures pixel array detectors for medical imaging. Luis Pallares has been the CEO of the company since 2020. | Président | - |
Formation de Patrick Scherrer
| Université de Neuchâtel | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CORETECH 5 | Process Industries |
| Entreprise privées | 8 |
|---|---|
| The European Tech Tour Association | |
Alascom, Inc.
Alascom, Inc. Specialty TelecommunicationsCommunications Alascom, Inc. provides communications services. It offers mobility, network Security and service, cloud, television, hosting and voice services. The company was founded 1969 and is headquartered in Anchorage, AK. | Communications |
Evolva SA
Evolva SA Miscellaneous Commercial ServicesCommercial Services Evolva SA is a Swiss-headquartered, international pharmaceutical biotech company focused on the discovery and development of drugs based on its distinctive and proprietary genetic chemistry platform. The company was founded in Switzerland in 2004 based on US/Danish technology. Evolva is headquartered in Allschwil/Basel with operations in Denmark, India and the USA. The Company has raised CHF 38.2 million of equity to date and employs 75 persons of whom 30 are based in Allschwil. The firm's strategy and business approach is based on five pillars that offer a sustainable development path for creating a successful company, which include Building a balanced portfolio. Evolva focuses on orally available small molecules in the belief that they are more convenient for patients and more cost-effective both from manufacture and administration points of view for the society, focus on differentiated pharmaceutical products with major benefits. Focusing on cardiovascular/renal and infectious diseases. Together they cause more than 50% of all deaths worldwide. Most of the top 20 pharmaceutical companies are active in both sectors, and all are active in one of the two sectors - hence widening Evolva's opportunities to partner. Building technology platform as the source of this differentiation. Evolva finds different structures with different properties from those found by the 99% of the industry that focuses on synthetic chemistry or proteins. Openness to unusual markets. The biotech business model has changed. As well as the established markets new opportunities arise in emerging countries such as India and China, and in adjacent sectors such as treatments against potential bio-terrorist and bio-warfare agents and the production of pharmaceutical and industrial chemical intermediates. Cost-effective implementation. Evolva places different functions around the globe according to where local conditions best suit. This approach both reduces Evolva's cost base and increases access to revenues, partners and talent. Evolva sees revenues and partners as important because they provide additional flexibility, resources and talent. Also, they provide important opportunities to better understand, and better meet, the needs of current and future customers. | Commercial Services |
Sensimed SA
 Sensimed SA Medical SpecialtiesHealth Technology Sensimed SA develops non-invasive soft contact lens-based solutions. It offers solutions to monitor fluctuations in intraocular pressure continuously. The company was founded by Matteo Leonardi and Sacha Cerboni in 2003 and is headquartered in Lausanne, Switzerland. | Health Technology |
| Widmann Associates Ltd. | |
| Hewlett-Packard EMEA | |
G-Ray Medical Sàrl
G-Ray Medical Sàrl Medical SpecialtiesHealth Technology G-Ray Medical Sàrl is a private company based in Hauterive, Switzerland. The Swiss company manufactures pixel array detectors for medical imaging. Luis Pallares has been the CEO of the company since 2020. | Health Technology |
G-ray Switzerland SA
G-ray Switzerland SA Medical/Nursing ServicesHealth Services G-ray Switzerland SA is a private company based in Hauterive, Switzerland that was founded in 2014 by Patrick Scherrer, Hans von Känel, Daniel A. Rüfenacht, and Adolfo Fucci. The Swiss company specializes in radiographic imaging and new semiconductor assembly techniques, and has filed a number of revolutionary patents in these fields. The company has developed core skills in monolithic detectors with integrated high-resolution CMOS circuits, which have applications in various sectors such as automotive, aerospace, and medicine. Luis Pallares has been the CEO of the company since 2020. | Health Services |